Xolair 150 MG/ML syringeml

Ended Awarded Last action

Contract number
SPE2DR26FHGX8
Awardee
Awarding agency
Obligated
$37,901

Award facts

Contract value 100% obligated
$37,901.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for $37,901.28 (ceiling value) to supply Xolair 150 mg/ml syringes.

DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge, Illinois. Ultimate completion date is March 3, 2026.

Quick answers

Who was awarded contract SPE2DR26FHGX8?

SPE2DR26FHGX8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 9, 2026.

How much is contract SPE2DR26FHGX8 worth?

The government has obligated $37,901 on SPE2DR26FHGX8.

Is contract SPE2DR26FHGX8 an order under another contract?

Yes. SPE2DR26FHGX8 is a delivery order under SPE2DR25D9244, an indefinite delivery contract.

Was contract SPE2DR26FHGX8 competed?

The extent of competition for SPE2DR26FHGX8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award